Correction: Bortezomib for anti-NMDAR encephalitis following daclizumab treatment in a patient with multiple sclerosis

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313866/
https://www.ncbi.nlm.nih.gov/pubmed/34396130
http://dx.doi.org/10.1136/bmjno-2020-000096corr1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313866/
https://www.ncbi.nlm.nih.gov/pubmed/34396130
http://dx.doi.org/10.1136/bmjno-2020-000096corr1

Ejemplares similares